The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations.
Curr Atheroscler Rep
; 25(7): 351-357, 2023 07.
Article
Dans Anglais
| MEDLINE | ID: covidwho-2317609
ABSTRACT
PURPOSE OF REVIEW Despite single-photon emission computerized tomography (SPECT) being the most used nuclear imaging technique for diagnosis of coronary artery disease (CAD), many now consider positron emission tomography (PET) as a superior modality. This review will focus on the advances of cardiac PET in recent years and its advantages compared to SPECT in diagnosis and prognosis of CAD. RECENT FINDINGS:
PET's higher resolution and enhanced diagnostic accuracy, as well as lower radiation exposure, all help explain the rationale for its wider spread and use. PET also allows for measurement of myocardial blood flow (MBF) and myocardial flow reserve (MFR), which aids in several different clinical scenarios, such as diagnosing multivessel disease or identifying non-responders. PET has also been shown to be useful in diagnosing CAD in various specific populations, such as patients with prior COVID-19 infection, cardiac transplant, and other comorbidities.Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
Maladie des artères coronaires
/
Ischémie myocardique
/
Fraction du flux de réserve coronaire
/
Imagerie de perfusion myocardique
/
COVID-19
Type d'étude:
Étude pronostique
Limites du sujet:
Humains
langue:
Anglais
Revue:
Curr Atheroscler Rep
Thème du journal:
Maladies vasculaires
Année:
2023
Type de document:
Article
Pays d'affiliation:
S11883-023-01107-0
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS